We are live on ! Find out more
EWTX icon

Edgewise Therapeutics

58 hedge funds and large institutions have $769M invested in Edgewise Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 4

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

21% more funds holding

Funds holding: 4858 (+10)

4.58% more ownership

Funds ownership: 97.52%102.09% (+4.6%)

3% less capital invested

Capital invested by funds: $796M → $769M (-$26.4M)

Holders
58
Holders Change
+10
Holders Change %
+20.83%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
17
Increased
25
Reduced
4
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$1.8M +$1.16M +64,387 +222%
TCM
27
Tekla Capital Management
Massachusetts
$925K +$1.09M +60,550 New
Goldman Sachs
28
Goldman Sachs
New York
$619K +$729K +40,512 New
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$466K +$549K +30,511 New
Bank of America
30
Bank of America
North Carolina
$440K +$469K +26,046 +951%
Deutsche Bank
31
Deutsche Bank
Germany
$374K +$308K +17,124 +232%
JP Morgan Chase
32
JP Morgan Chase
New York
$337K +$261K +14,531 +194%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$322K +$261K +14,480 +219%
AIG
34
American International Group
New York
$314K +$244K +13,568 +194%
QPW
35
Quantum Private Wealth
Florida
$295K +$348K +19,352 New
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$282K +$139K +7,735 +72%
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
$276K +$325K +18,078 New
Wells Fargo
38
Wells Fargo
California
$273K +$321K +17,852 New
DekaBank Deutsche Girozentrale
39
DekaBank Deutsche Girozentrale
Germany
$269K +$324K +18,000 New
Morgan Stanley
40
Morgan Stanley
New York
$262K +$293K +16,311 +1,883%
Invesco
41
Invesco
Georgia
$252K +$297K +16,517 New
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$244K
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$239K +$256K +14,251 +1,017%
ProShare Advisors
44
ProShare Advisors
Maryland
$235K +$277K +15,393 New
MIM
45
MetLife Investment Management
New Jersey
$230K +$270K +15,027 New
TI
46
Trexquant Investment
Connecticut
$214K +$252K +14,023 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$208K +$244K +13,587 New
Squarepoint
48
Squarepoint
New York
$186K +$219K +12,197 New
Citigroup
49
Citigroup
New York
$173K +$177K +9,839 +657%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$170K +$200K +11,132 New

EWTX Hedge Fund Activity: Q4 2021 in Review

58 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q4 2021, worth a combined $769M — down 3.3% from $796M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new EWTX positions and 7 closed out — a net gain of 10 holders — while 25 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Fidelity Investments, cutting an estimated $11.8M.

  • 58 institutional investors held Edgewise Therapeutics (EWTX) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $769M of Edgewise Therapeutics stock for Q4 2021, down 3.3% quarter-over-quarter.
  • 17 funds opened new Edgewise Therapeutics positions in Q4 2021 and 7 closed out, a net change of +10 holders.
  • The largest Edgewise Therapeutics buyer in Q4 2021 was BlackRock, an estimated $26.4M added.
  • The largest Edgewise Therapeutics seller in Q4 2021 was Fidelity Investments, an estimated $11.8M sold.

Based on aggregated 13F filings for Q4 2021.